Metaplanet Revives Stock Price! Announces ’Share Buyback’ Plan Backed by Bitcoin (BTC) Collateral

Corporate treasury strategy gets a crypto makeover as traditional finance meets digital assets head-on.

The Bitcoin-Backed Bailout

Metaplanet unveils a radical approach to corporate finance—leveraging Bitcoin holdings as collateral for share repurchases. The $48 million war chest signals a fundamental shift in how public companies manage their balance sheets.

Digital Assets Meet Traditional Markets

By using BTC as collateral instead of conventional assets, Metaplanet bypasses traditional banking channels entirely. The move demonstrates growing institutional confidence in cryptocurrency as legitimate corporate treasury assets.

Market Mechanics in Motion

The announcement immediately boosted shareholder confidence, proving that sometimes the best way to save a traditional business is through decidedly non-traditional means—because nothing says financial stability like volatile cryptocurrency collateral.

As legacy institutions watch from the sidelines, Metaplanet's bold gamble could either redefine corporate finance or provide ample material for future business school case studies on what not to do with your treasury reserves.

TLDR

• Prenetics has raised $48M in equity to support its bitcoin and IM8 growth plans.
• The company currently holds 275 BTC, worth around $31 million as of Oct 27.
• IM8 hit $100M in recurring revenue just 11 months after its launch.
• Prenetics aims for $1B in bitcoin holdings and annual revenue in five years.

Prenetics Global, a Nasdaq-listed health sciences company, has raised $48 million in new funding to grow its Bitcoin holdings and expand its supplement brand IM8. The company said the equity offering was oversubscribed and backed by a mix of crypto-focused firms and high-profile investors. Prenetics plans to use the fresh capital to support its treasury strategy and global business goals.

$48 Million Raised to Support Bitcoin and IM8 Growth

Prenetics Global announced it has secured $48 million in gross proceeds from an equity offering, which was oversubscribed. The company confirmed this in a statement released on Monday, October 28, 2025. The offering attracted interest from crypto investment firms such as Kraken, Exodus, GPTX by Jihan Wu, DL Holdings, and American Ventures.

The company said the deal could generate up to $216 million in total proceeds if all warrants are exercised. Tennis player Aryna Sabalenka and Hong Kong businessman Adrian Cheng also increased their stakes in the company. Prenetics counts football star David Beckham as one of its existing shareholders.

CEO Danny Yeung said the new funds will be used to “accelerate IM8’s global expansion while advancing our disciplined bitcoin treasury initiatives.”

Prenetics Expands Bitcoin Treasury Strategy

Prenetics began its bitcoin treasury initiative in August 2025, following an announcement in June. The company committed to buying one bitcoin daily as part of its strategy. As of October 27, the company holds around 275 BTC, valued at roughly $31 million.

With the funds from this round, Prenetics expects to have around $131 million in liquidity. The company confirmed that it will continue with its BTC accumulation strategy, aiming to expand both digital asset holdings and business operations in parallel.

Yeung said Prenetics is targeting long-term goals of reaching $1 billion in both annual revenue and bitcoin holdings within five years.

IM8 Supplement Brand Shows Fast Revenue Growth

Alongside its crypto strategy, Prenetics is also focusing on expanding IM8, its supplement brand co-founded with David Beckham. IM8 has generated $100 million in recurring revenue within 11 months of launch, the company said. It is now projecting revenue between $160 million and $200 million in 2026.

The brand has gained popularity quickly and will now benefit from increased investment as part of the broader company growth strategy. IM8 is part of Prenetics’ consumer health unit, which plays a central role in the firm’s business model.

The company said the new capital will be used to expand IM8 into global markets, increasing its reach and product offerings over the next year.

Stock Reaction and Outlook

Despite the new funding, Prenetics’ stock dropped 21.96% to close at $13.08 on Monday. However, it gained 4.51% in after-hours trading, according to Yahoo Finance. Over the past five days, the stock has declined by 19.46%, although it remains up over 161% in the last six months.

The equity raise comes during a volatile time in the market, yet investors appeared confident in the firm’s dual strategy focusing on health products and digital assets. With strong backers and a clear plan, the company is pushing ahead with both bitcoin accumulation and business growth.